Cytodyn Inc (CYDY)

[stockorus]

I know shorts are having a field day with this point, but I am just as nervous about our trials not starting even 3 weeks after ANVISA approving cd17. It doesn't look normal to me.

Different reasons possible or talked about:

1. Not enough cash to run trials
2. BIOMM is waiting for final notes from ANVISA
3. BIOMM is waiting for LL to be imported (*Just saw that Nader is pointing to this reason as the primary difficulty, which has been overcome now. But not clear what other hurdles they face.)
4. Covid situation is improving fast in Brazil, so new severe/critical patients not coming in large numbers and opting to participate in our trials. Lost time is lost opportunity for this indication.

Cytodyn and others have done too much work to get this far and not have the trials go on and give LL a final chance to prove itself in Covid. At this point am mainly looking for updates on this. Good to know cancer, HIV etc. but time for Covid is NOW.